From January 18, 2024 to March 31, 2024, the company has repurchased 2,476,300 shares, representing 0.27% for HKD 60.36 million. With this, the company has completed the repurchase of 2,476,300 shares, representing 0.27% for HKD 60.36 million under the buyback announced on January 19, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.21 CNY | -0.62% | -5.19% | +9.14% |
May. 14 | Livzon Pharmaceutical Group Cancels Share Options | MT |
May. 14 | Livzon Pharmaceutical Declares Final Dividend for 2023 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.14% | 4.33B | |
+37.74% | 723B | |
+34.69% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.19% | 244B | |
+10.03% | 208B | |
-3.97% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Tranche Update on Livzon Pharmaceutical Group Inc.'s Equity Buyback Plan announced on January 19, 2024.